Accurate Suicide Risk Detection With eC-SSRS Helps Ensure Safety of Trial Participants and Treatments in Oncology and Beyond Webinar Replay
Protecting patients, compounds and proving benefits: How accurately accessing suicide risk detection with eC-SSRS/C-SSRS helps ensure clinical trial participants and their treatments remain safe in oncology and beyond.
Join esteemed speakers, Dr. Kelly Posner, Dr. John Greist and Libby Thomas for a deep dive into the nuances of accurately assessing suicide risk, including how the Columbia-Suicide Severity Rating Scale (Clinician reported: C-SSRS, patient self-report: eC-SSRS) is benefiting clinical trials by protecting patients, protecting drug compounds and more.
Subscribe to our newsletter
Stay up to date with the latest insights and best practices by subscribing to our newsletter. You’ll receive notifications whenever we publish new webinar replays, blog posts and other downloadable resources.